NO996514L - Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom - Google Patents
Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av LymesykdomInfo
- Publication number
- NO996514L NO996514L NO996514A NO996514A NO996514L NO 996514 L NO996514 L NO 996514L NO 996514 A NO996514 A NO 996514A NO 996514 A NO996514 A NO 996514A NO 996514 L NO996514 L NO 996514L
- Authority
- NO
- Norway
- Prior art keywords
- diagnosis
- lyme disease
- prevention
- compositions
- surface antigens
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 4
- 102000036639 antigens Human genes 0.000 title abstract 4
- 108091007433 antigens Proteins 0.000 title abstract 4
- 208000016604 Lyme disease Diseases 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title 1
- 241000908522 Borreliella Species 0.000 abstract 3
- 241000589970 Spirochaetales Species 0.000 abstract 2
- 238000000338 in vitro Methods 0.000 abstract 2
- 241000589968 Borrelia Species 0.000 abstract 1
- 101100108136 Drosophila melanogaster Adck1 gene Proteins 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5127197P | 1997-06-30 | 1997-06-30 | |
PCT/US1998/013551 WO1999000413A1 (fr) | 1997-06-30 | 1998-06-29 | Antigenes de surface et proteines utiles dans des compositions utilisees pour le diagnostic et la prevention de la maladie de lyme |
Publications (2)
Publication Number | Publication Date |
---|---|
NO996514D0 NO996514D0 (no) | 1999-12-28 |
NO996514L true NO996514L (no) | 2000-02-14 |
Family
ID=21970280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO996514A NO996514L (no) | 1997-06-30 | 1999-12-28 | Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom |
Country Status (17)
Country | Link |
---|---|
US (2) | US6660274B2 (fr) |
EP (1) | EP1012181B1 (fr) |
JP (1) | JP2002511760A (fr) |
KR (1) | KR20010020567A (fr) |
CN (1) | CN1261896A (fr) |
AR (1) | AR016295A1 (fr) |
AT (1) | ATE337335T1 (fr) |
AU (1) | AU8177298A (fr) |
CA (1) | CA2294701C (fr) |
CO (1) | CO4790101A1 (fr) |
DE (1) | DE69835682T2 (fr) |
DK (1) | DK1012181T3 (fr) |
ES (1) | ES2270523T3 (fr) |
NO (1) | NO996514L (fr) |
PL (1) | PL337667A1 (fr) |
WO (1) | WO1999000413A1 (fr) |
ZA (1) | ZA985704B (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69733944T3 (de) | 1996-02-21 | 2012-07-26 | The Board Of Regents, The University Of Texas System | Vmp-ähnliche sequenzen von pathogener borrelia |
CA2294701C (fr) * | 1997-06-30 | 2009-09-08 | The Administrators Of The Tulane Educational Fund | Antigenes de surface et proteines utiles dans des compositions utilisees pour le diagnostic et la prevention de la maladie de lyme |
US6475492B1 (en) | 1999-04-28 | 2002-11-05 | The Administrators Of The Tulane Educational Fund | Peptides and assays for the diagnosis of lyme disease |
EP2292762A3 (fr) | 2002-12-20 | 2012-12-12 | Board of Regents, The University of Texas System | Séquences d'espèces et de souches de Borrelia pathogène de type VMP |
WO2007133623A2 (fr) * | 2006-05-10 | 2007-11-22 | Biopeptides Corporation | Agent de diagnostic peptidique pour la maladie de lyme |
EP2077856B1 (fr) * | 2006-11-03 | 2015-08-12 | Intervet International BV | Vaccin contre la maladie de lyme canine |
ES2337113B1 (es) * | 2007-04-17 | 2011-01-24 | Centre De Recerca En Sanitat Animal (Cresa) | Empleo de la hemaglutinina del virus de la peste porcina africana como adyuvante. |
WO2009033163A2 (fr) * | 2007-09-07 | 2009-03-12 | The Regents Of The University Of California | Procédés de diagnostic et de criblage concernant borrelia |
WO2010132758A2 (fr) * | 2009-05-14 | 2010-11-18 | Gomes-Solecki Maria J | Test de diagnostic à base de ospc pour la maladie de lyme |
CN102791727A (zh) | 2009-11-17 | 2012-11-21 | 爱贝斯股份有限公司 | 用于检测莱姆病抗体的肽和方法 |
KR102222869B1 (ko) * | 2010-05-14 | 2021-03-04 | 박스알타 인코퍼레이티드 | 키메라 ospa 유전자, 단백질 및 이의 사용 방법 |
CA2812759A1 (fr) | 2010-09-27 | 2012-04-12 | Cornell University | Procedes de diagnostic de la maladie de lyme |
US10100092B2 (en) | 2011-11-03 | 2018-10-16 | Vca, Inc. | Compositions and methods to detect various infectious organisms |
US8758772B2 (en) | 2011-11-04 | 2014-06-24 | Abaxis, Inc. | Peptides and methods for the detection of lyme disease antibodies |
US9670537B2 (en) | 2014-06-06 | 2017-06-06 | Titan Collaborative Kithe, Llc | Borrelia Provocation Procedure kit |
WO2016049148A1 (fr) | 2014-09-24 | 2016-03-31 | Wellstat Diagnostics, Llc | Compositions et méthodes de diagnostic de la maladie de lyme |
WO2017035389A1 (fr) | 2015-08-27 | 2017-03-02 | Quidel Corporation | Dispositif d'analyse par dosage immunologique comportant deux trajets d'écoulement de fluide pour la détection et la différentiation d'au moins deux analytes |
CN106432487A (zh) * | 2016-10-31 | 2017-02-22 | 杭州贝英福生物科技有限公司 | 一种伽氏疏螺旋体多克隆抗体及应用 |
CN106397589A (zh) * | 2016-10-31 | 2017-02-15 | 杭州贝英福生物科技有限公司 | 一种狭义伯氏疏螺旋体多克隆抗体及应用 |
JP2020507772A (ja) | 2017-02-10 | 2020-03-12 | クイデル コーポレーション | 制御流体フロー用チャネルを有する基材を用いたラテラルフローアッセイ |
CN109596824A (zh) * | 2019-01-04 | 2019-04-09 | 杭州奥泰生物技术股份有限公司 | 一种快速诊断莱姆病的检测试纸及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US485551A (en) | 1892-11-01 | And william | ||
DK590288D0 (da) * | 1988-10-24 | 1988-10-24 | Symbicom Ab | Kemiske forbindelser |
EP0339695A3 (fr) | 1988-04-29 | 1990-05-30 | Stichting Voor De Technische Wetenschappen | Procédé de préparation d'un conjugué antigénique ou immunogénique ainsi que l'utilisation de tels conjugués |
CA2072008C (fr) | 1989-12-22 | 2003-01-28 | Renate Fuchs | Proteines a activite immunologique provenant de borrelia burgdorferi, trousses de dosage contenant ces proteines et permettant la detection d'anticorps dans des milieux liquides, et utilisation de ces proteines comme vaccins contre les infections causees par differentes souches de borrelia |
US5217872A (en) * | 1990-02-27 | 1993-06-08 | The United States Of America As Represented By The Department Of Health And Human Services | Method for detection of borrelia burgdorferi antigens |
DE69122240T2 (de) | 1990-03-05 | 1997-02-13 | The United States of America, represented by the Secretary, U.S. Department of Commerce, Washington, D.C. | Antigen-wirkende proteine von borrelia burgdorferi |
JPH06501382A (ja) | 1990-06-15 | 1994-02-17 | エール ユニバーシティ | ライム病の予防および診断に用いる組成物および方法 |
EP1016416A3 (fr) * | 1990-07-06 | 2002-10-23 | Wyeth | Vaccin contre la maladie de lyme et modèle pour l'évaluation de l'efficacité du vaccin |
DE69733944T3 (de) * | 1996-02-21 | 2012-07-26 | The Board Of Regents, The University Of Texas System | Vmp-ähnliche sequenzen von pathogener borrelia |
DE19632862B4 (de) * | 1996-08-14 | 2006-08-03 | Mikrogen Molekularbiologische Entwicklungs-Gmbh | Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe |
CA2294701C (fr) * | 1997-06-30 | 2009-09-08 | The Administrators Of The Tulane Educational Fund | Antigenes de surface et proteines utiles dans des compositions utilisees pour le diagnostic et la prevention de la maladie de lyme |
US6475492B1 (en) * | 1999-04-28 | 2002-11-05 | The Administrators Of The Tulane Educational Fund | Peptides and assays for the diagnosis of lyme disease |
-
1998
- 1998-06-29 CA CA002294701A patent/CA2294701C/fr not_active Expired - Lifetime
- 1998-06-29 AU AU81772/98A patent/AU8177298A/en not_active Abandoned
- 1998-06-29 AT AT98931729T patent/ATE337335T1/de active
- 1998-06-29 JP JP50587199A patent/JP2002511760A/ja active Pending
- 1998-06-29 WO PCT/US1998/013551 patent/WO1999000413A1/fr active IP Right Grant
- 1998-06-29 DK DK98931729T patent/DK1012181T3/da active
- 1998-06-29 DE DE69835682T patent/DE69835682T2/de not_active Expired - Lifetime
- 1998-06-29 PL PL98337667A patent/PL337667A1/xx unknown
- 1998-06-29 EP EP98931729A patent/EP1012181B1/fr not_active Expired - Lifetime
- 1998-06-29 US US09/445,803 patent/US6660274B2/en not_active Expired - Lifetime
- 1998-06-29 KR KR1019997012472A patent/KR20010020567A/ko not_active Application Discontinuation
- 1998-06-29 CN CN98806699A patent/CN1261896A/zh active Pending
- 1998-06-29 ES ES98931729T patent/ES2270523T3/es not_active Expired - Lifetime
- 1998-06-30 CO CO98036847A patent/CO4790101A1/es unknown
- 1998-06-30 ZA ZA985704A patent/ZA985704B/xx unknown
- 1998-06-30 AR ARP980103181A patent/AR016295A1/es unknown
-
1999
- 1999-12-28 NO NO996514A patent/NO996514L/no not_active Application Discontinuation
-
2003
- 2003-08-01 US US10/632,780 patent/US20040067517A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2294701C (fr) | 2009-09-08 |
ZA985704B (en) | 1999-01-13 |
AU8177298A (en) | 1999-01-19 |
JP2002511760A (ja) | 2002-04-16 |
PL337667A1 (en) | 2000-08-28 |
US6660274B2 (en) | 2003-12-09 |
DE69835682D1 (de) | 2006-10-05 |
ATE337335T1 (de) | 2006-09-15 |
CN1261896A (zh) | 2000-08-02 |
AR016295A1 (es) | 2001-07-04 |
WO1999000413A1 (fr) | 1999-01-07 |
DK1012181T3 (da) | 2007-01-02 |
NO996514D0 (no) | 1999-12-28 |
DE69835682T2 (de) | 2007-08-23 |
KR20010020567A (ko) | 2001-03-15 |
US20030059894A1 (en) | 2003-03-27 |
CA2294701A1 (fr) | 1999-01-07 |
US20040067517A1 (en) | 2004-04-08 |
EP1012181A1 (fr) | 2000-06-28 |
ES2270523T3 (es) | 2007-04-01 |
EP1012181B1 (fr) | 2006-08-23 |
CO4790101A1 (es) | 1999-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO996514L (no) | Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom | |
CY1117387T1 (el) | ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ Ν-11 ΔΙΑΣΠΑΣΜΕΝΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, ΣΥΝΘΕΣΕΙΣ, ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ | |
BR9714160A (pt) | Antìgenos uspa1 e uspa2 de moraxella catarrhalis | |
WO2005056600A3 (fr) | Anticorps monoclonaux se liant ou neutralisant le virus de la dengue | |
ATE165395T1 (de) | Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen | |
WO2000077216A3 (fr) | Vaccin poxvirus recombine contre le circovirus porcin | |
BR9610872A (pt) | Proteìna receptora de transferrina de moraxella | |
SE0103754L (sv) | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid | |
ATE453403T1 (de) | Wirtszelle enthaltend ein rekombinantes virus, welches ein antigen exprimiert und ein rekombinantes virus, welches ein immunstimulatorisches molekül exprimiert | |
EP1731166A3 (fr) | Protéines et vaccins de streptococcus pneumoniae | |
WO2003083485A3 (fr) | Proteine destinee a etre utilisee dans des etats lies a une hypoxie | |
AU2001276619A1 (en) | Immunisation against chlamydia pneumoniae | |
EP0683234A4 (fr) | ANTICORPS DIRIGE CONTRE LE -g(b)-AMYLOIDE OU UN DERIVE DE CE DERNIER ET SON UTILISATION. | |
EP0090581A3 (fr) | Petits peptides specifiques des antigènes de la fièvre aphteuse | |
DE60036698D1 (de) | Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen | |
ATE132197T1 (de) | Monoklonale antikörper | |
NO331277B1 (no) | Farmasoytisk sammensetning omfattende polypetid/nukleinsyre for behandling av retinale degenererende sykdommer, vektor, isolert polypeptid, renset antistoff og anvendelse av polypeptid, nukleinsyre og antistoff, samt fremgangsmater og kit | |
UA42040C2 (uk) | Поліпептид, спосіб діагностики інсулінозалежного цукрового діабету (iddm), що розвинувся або що розвивається (варіанти), набір для діагностики iddm (варіанти), препарат для запобігання або лікування iddm, фармацевтична композиція для профілактики або лікування iddm | |
ATE142888T1 (de) | Antigen-wirkende proteine von borrelia burgdorferi | |
DE69737323D1 (de) | Adhesin aus heliobacter pylori, welches an blutgruppenantigene bindet | |
BR0207528A (pt) | Anticorpo, composição farmacêutica, e, usos de uma quantidade efetiva de um agente, de uma quantidade terapeuticamente efetiva de um anticorpo para il-22, de uma quantidade imunogênica do antìgeno e uma quantidade aumentadora de imunogenicidade de il-22 em combinação, de uma quantidade efetiva do anticorpo ou fragmento do mesmo e de uma quantidade suficiente de anticorpo ou fragmento ligado a antìgeno do mesmo | |
DE69233311D1 (de) | Weidelgraspollen-allergen | |
AU2002310474A1 (en) | Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same | |
PT868522E (pt) | Virus recombinante de poxvirus - virus da peritonite infecciosa felina, suas composicoes e metodos para a sua preparacao e utilizacao | |
DE69738770D1 (de) | Porphyromonas gingivalis Antigene zur Diagnose und Behandlung von Periodontitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |